Displaying 51 - 60 of 73 for Pediatrics
  • Osteogenesis Imperfecta (H-36030)
    • The purpose of the study is to determine whether treatment with Denosumab is safe and effective in children with osteogenesis imperfecta.
  • Parenting Study (H-26732)
    • This is a double-blinded, randomized controlled trial of intranasal oxytocin, examining paternal brain and behavioral responses to infant cues.
  • Peanut Allergy Study (H-26819)
    • The purpose of this study is to determine which participants can safely develop oral tolerance to peanuts from a three-year peanut oral immunotherapy trial.
  • Peanut Allergy Study (H-38033)
    • The purpose of this research study is to collect information about the effectiveness and safety of the experimental drug, AR101, as immunotherapy treatment of food allergy for peanut-allergic children and adults.
  • Peppermint Oil Study in Children (H-40351)
    • The purpose of this study to find out how much peppermint oil we should give to treat children who have frequent belly pain and to learn how peppermint oil works to relieve pain.
  • Post-Discharge Growth of Infants Who Received Donor Human Milk Products in the NICU (H-29522)
    • The purpose of this study is to evaluate post-discharge growth and neurodevelopmental outcomes in infants ≤ 1250 grams birth weight receiving an exclusive human milk diet.
  • PREVALE Study (H-39090)
    • The purpose of this study is to find out if LMP-specific EB-VST cells in combination with nivolumab are safe, to learn what the side effects are, and to see whether this therapy may help patients with EBV related lymphoma or LPD.
  • Primary Haemophagocytic Lymphohistiocytosis Study (H-33362)
    • The purpose of this study is to assess the safety, tolerability and efficacy of a new drug aimed at controlling disease activity in patients diagnosed with primary haemophagocytic lymphohistiocytosis.
  • Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (H-38468)
    • The purpose of this study is to determine the safety and efficacy of KTE-C19 in relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) in pediatric or adolescent subjects.
  • RELY-30 Study (H-37966)
    • In this study lymphodepletion chemotherapy will be administered in patients who are not post autologous transplant in the hope that it will result in more durable anti-tumor effects.